Choudhery Mahmood S, Arif Taqdees, Mahmood Ruhma, Harris David T
Department of Human Genetics & Molecular Biology, University of Health Sciences, Lahore 54000, Pakistan.
Allama Iqbal Medical College, Jinnah Hospital, Lahore 54000, Pakistan.
Biomolecules. 2025 Apr 10;15(4):558. doi: 10.3390/biom15040558.
Stroke occurs when the blood flow to the brain is interrupted due to a rupture of blood vessels or blockage in the brain. It is the major cause of physical disabilities in adulthood. Despite advances in surgical and pharmacological therapy, functional recovery from stroke is limited, affecting quality of life. Stem cell therapy, which may treat neurological disorders associated with brain traumas, including stroke, is an important focus in stroke research and treatment. Stem cell therapy has primarily used a type of adult stem cells called mesenchymal stem cells (MSCs) due to their universality and ability to develop into multiple lineages to regenerate brain cells and repair brain tissues. A significant number of clinical studies provide evidence of the potential of MSCs to treat stroke. This review summarizes the therapeutic mechanism and applications of MSCs in stroke treatment. We also highlight the current challenges and future prospects of adult MSC therapy for stroke treatment.
当流向大脑的血液因血管破裂或脑部堵塞而中断时,就会发生中风。它是成年人身体残疾的主要原因。尽管手术和药物治疗取得了进展,但中风后的功能恢复仍然有限,影响生活质量。干细胞疗法可能治疗与脑外伤相关的神经系统疾病,包括中风,是中风研究和治疗的一个重要重点。干细胞疗法主要使用一种称为间充质干细胞(MSCs)的成体干细胞,因为它们具有通用性,并且能够发育成多种谱系以再生脑细胞和修复脑组织。大量临床研究提供了间充质干细胞治疗中风潜力的证据。本综述总结了间充质干细胞在中风治疗中的治疗机制和应用。我们还强调了成人间充质干细胞治疗中风的当前挑战和未来前景。